Innoviva, Inc. (INVA) Social Stream



Innoviva, Inc. (INVA): $15.22

0.33 (+2.22%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add INVA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 400

in industry

Innoviva Inc (INVA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Innoviva Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-12 1 $10 $10 $10 $19.65 -49.11%
2022-02-24 1 $12 $12 $12 $19.65 -38.93%

Price Target Last Issued February 24, 2022

The Trend in the Analyst Price Target


Over the past 22 months, INVA's average price target has gone up $4.

INVA reports an average of -28.17% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 1 10 10 10 11.70 -14.53%
2021-06-13 1 10 10 10 12.60 -20.63%
2021-07-03 1 10 10 10 13.64 -26.69%
2021-08-01 1 10 10 10 14.18 -29.48%
2021-09-04 1 10 10 10 15.36 -34.9%

INVA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
4.3 0 0 0 1 1 1

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for INVA as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, Innoviva Inc's number of analysts covering the stock is higher than nearly none of them.
  • In terms of how Innoviva Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than just about 100% of that group.
  • In terms of how Innoviva Inc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 0.05% of that group.
  • In the context of stocks in the mid market cap category, Innoviva Inc's average analyst price target is higher than 14.67% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Innoviva Inc are INSM, INFI, and IMAB.

Is INVA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4725 seconds.